Viral Hepatitis

This online course teaches the user how to evaluate abnormal liver chemistries in the context of a broad understanding of the pathophysiology of liver injury. It is designed for providers who are non-liver specialists, particularly mid-level healthcare providers. Participants will learn common differential diagnosis for each pattern of liver injury, to initiate appropriate investigations based on the pattern of liver injury, recognize clinical manifestations of hepatic failure, and identify patients with liver disease who require hospitalization.

This internet file (web page) provides lessons on co-infection of HIV and hepatitis C. It discusses treatment; responder relapsers, partial responders, and null responders; experimental treatment; preventing cellular infection; viral enzyme target; immune therapies; and prevention. It includes two video clips, one with a hepatitis C patient, who relates her story, and the other with a doctor explains the importance of knowing about HCV for HIV infected individuals.

This workbook is designed for patient's use throughout treatment with triple therapy--pegylated interferon, ribavirin, and boceprevir. The workbook explains triple therapy, how and when to take medications, what to do if you miss a dose, the length of treatment, if treament does not work, treatment tracks and which you should follow, and dealing with side effects. It provides sample medication schedules, a viral load chart, the notes to bring to the provider, and treatment visit schedule.

This information sheet discusses the hepatitis B vaccine. It presents statistics on the incidence of hepatitis B in the United States and describes the hepatitis B virus (HBV) and its effect on the liver, the symptoms, the difference between acute (short-term) illness and chronic (long-term) infection, transmission, and prevention.

This information sheet presents facts about viral hepatitis in tabular format. It discusses hepatitis A, B, and C. It lists statistics; routes of transmission; persons at risk; incubation period; symptoms of acute infection; the likelihood of symptomatic acute infection; the potential for chronic infection; the severity; serologic tests for acute and chronic infection; screening recommendations for chronic infection; treatment; vaccination recommendations and schedule, if any; and testing recommendations.

This information sheet discusses the hepatitis B vaccine. It presents statistics on the incidence of hepatitis B in the United States and describes the hepatitis B virus (HBV) and its effect on the liver, the symptoms, the difference between acute (short-term) illness and chronic (long-term) infection, transmission, and prevention.

This information sheet discusses the hepatitis B vaccine. It presents statistics on the incidence of hepatitis B in the United States and describes the hepatitis B virus (HBV) and its effect on the liver, the symptoms, the difference between acute (short-term) illness and chronic (long-term) infection, transmission, and prevention.

This information sheet discusses what Hepatitis C is and why baby boomers should get tested for Hepatitis C. It states that an estimated three million adults in the US have Hepatitis C and that baby boomers are five times more likely to have Hepatitis C due to contaminated blood and blood products before widepread screening of blood in 1992 and other precautions were adopted or from injecting drugs.

This information sheet explains hepatitis B for people from Africa. It describes the disease which is caused by hepatitis B virus infection, its transmission, its effect on the body, diagnostic test, and who should be tested. The information sheet also explains why people should be tested, treatment, and where to get more information.